Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).
Clinical trial NCT07503730 · RECRUITING
Trial details
- NCT number
- NCT07503730
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.